Latest News


Affymax gets $5M milestone payment

American City Business Journals | 1 hour 36 minutes ago

Affymax Inc. said Wednesday it received a $5 million development milestone payment from Takeda Pharmaceutical Co.... (more)


Naked Juice launches vegetable smoothies

Drug Store News | 2 hours 22 minutes ago

By Allison CerraMONROVIA, Calif. (Mar. 10) Naked Juice is making eating vegetables easier for picky eaters with the launch of two new vegetable rich smoothies.... (more)


Biogen, Roche halt trial of drug

AARP The Magazine | 3 hours 34 minutes ago

Biogen Idec Inc. (NASDAQ:BIIB) and its Swiss partner Roche Holding AG yesterday said they halted clinical trials of a new drug being tested on patients with rheumatoid arthritis and lupus after an outside monitoring panel warned its safety risks outweighed the benefits, resulting in an unspecified number of deaths.... (more)


Jackson Health System warns it could run out of medical supplies

Orlando Sentinel (Fla.) | 3 hours 36 minutes ago

Jackson Health System is close to insolvency and facing the specter of having one of its major vendors, Johnson & Johnson, shut off supplies unless the company receives a $1 million payment this week.... (more)


Affymax Receives $5 Million Milestone Payment On Initiation Of Phase 3 Clinical Trials For Hematide In Japan

TheStreet.com | 3 hours 36 minutes ago

Affymax, Inc. (Nasdaq: AFFY) today announced that it has received a $5 million development milestone payment from Takeda Pharmaceutical Company as part of the companies? exclusive global agreement to develop and commercialize Hematide?, Affymax?s investigational drug for the treatment of anemia in chronic renal failure patients.... (more)


Idera Pharmaceuticals announces net income of $3.9M for fourth-quarter 2009

News-Medical.Net | 3 hours 36 minutes ago

Idera Pharmaceuticals, Inc. (Nasdaq: IDRA) today reported financial results for the fourth quarter and full year ended December 31, 2009.... (more)


Zinc in dental adhesives can cause "horrific injuries," lawyer says

Philadelphia Inquirer, The | 3 hours 37 minutes ago

IT BEGAN with tingling and numbness in her feet. It came and went, so Lee Russo, a healthy 39-year-old, ignored the problem.... (more)


OSI Pharmaceuticals deploys Veeva Systems' SaaS CRM application

News-Medical.Net | 3 hours 38 minutes ago

Veeva Systems announced today that it will support OSI Pharmaceuticals, Inc. with its SaaS Customer Relationship Management (CRM) application, which OSI deployed to its sales team in February after a rapid implementation. OSI selected Veeva CRM® for its ease of use, relevant functionality, and speed.... (more)


Time for drug giants to jump into the patent pool?

Guardian (London), The | 3 hours 39 minutes ago

While drugmaking giant GlaxoSmithKline has picked up a load of good press for CEO Andrew Witty's developing world initiatives - from ploughing back some of the (tiny) profits made in Africa to the more interesting patent pool it announced for neglected tropical diseases - it is Californian rival Gilead that gets a higher approval rating at the moment from Aids campaigners... (more)


ADHD News Network Broadcast wins Shire and P2M coveted 2010 Telly Award

News-Medical.Net | 3 hours 40 minutes ago

After reviewing more than 13,000 entries, the Telly Awards® and their Silver Council announced the Shire and PharmtoMarket (P2M) produced "ADHD News Network Broadcast: 11/18/2009" had received the coveted 2010 Telly Award for video broadcasting and production.... (more)


Collective Brands, J. Crew, Facet Biotech, Navistar, Ness

MarketWatch | 3 hours 41 minutes ago

Among the companies whose shares are expected to see active trade in Wednesday's session are Abbott Labs, American Eagle, Children's Place, Collective Brands, J. Crew, Facet Biotech, Navistar and Ness.... (more)




 1  2  3  4  5  6  7  8  9 ...   Next >

255 Stories  |   RSS Feed



Sign up for BIO SmartBrief



Designed specifically for biotechnology industry professionals like you, BIO SmartBrief is a FREE daily e-mail newsletter. It provides the latest news and information you need to stay informed about important biotech issues. Learn more

Latest Blog Postsview more


Companies in the news